O-RAN-ALLIANCE
30.6.2022 09:35:12 CEST | Business Wire | Press release
Since its beginning in 2018, the O-RAN ALLIANCE’s mission has been transforming Radio Access Networks towards open, intelligent, virtualized and fully interoperable RAN. Now, the O-RAN Ecosystem counts more than 340 companies and institutions from all over the world. O-RAN’s emphasis on openness is reflected in its setup as an open technical organization, according to the WTO criteria, where incumbent as well as emerging industry players or academic institutions can join and contribute.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220630005362/en/
O-RAN ALLIANCE Industry Summit June 2022
The O-RAN ALLIANCE Industry Summit June 2022 concluded on June 29, 2022 and is now available for on-demand replay at our website .
O-RAN Certification and Badging Program in cooperation with Open Test and Integration Centres (OTIC)
O-RAN ALLIANCE has launched its Certification and Badging program. O-RAN certificates state that an equipment or function is conformant to O-RAN specifications, whereas the O-RAN badges confirm interoperability or end-to-end functionality of an O-RAN solution. O-RAN certificates and badges will be issued by the Open Testing and Integration Centers, or OTICs.
The OTICs provide collaborative, open, and impartial working environment to ensure consistency and quality of testing of O-RAN products and solutions. O-RAN ALLIANCE has just approved the 7th OTIC and first one in Americas: Kyrio O-RAN Test and Integration Lab hosted by CableLabs.
See the full list of approved OTICs at our website .
O-RAN next Generations Research Group will focus on future network standards
O-RAN ALLIANCE has formed its next Generations Research Group (nGRG).
“The nGRG will focus on research of open and intelligent RAN principles in 6G and future network standards,” said Chih-Lin I, Co-chair of O-RAN Technical Steering Committee and Chief Scientist, Wireless Technologies, China Mobile Research Institute. “We are seeing very positive uptake on nGRG from the O-RAN ecosystem as well as the academic sphere and we are looking forward to seeing further progress of the research.”
Open RAN Summit @ Fyuz to be held on 25-26 October 2022 in Madrid
O-RAN ALLIANCE is delighted to announce the Open RAN Summit @ Fyuz, powered by the O-RAN ALLIANCE and Telecom Infra Project, which will take place in Madrid on October 25-26, 2022. We welcome TIP as they join us for this combined event.
Designed to bring together stakeholders from across the ecosystem, the Open RAN Summit at Fyuz will deliver the latest from the industry as we drive towards more disaggregated, intelligent, open, and fully interoperable mobile networks. All of that, served in a unique experience combining technology with gastronomy to stir your imagination. Learn more and register at the Fyuz event website .
O-RAN Global PlugFest Spring 2022 concluded at 3 continents with 50 participants
Starting from this year, O-RAN ALLIANCE switches to hosting two global PlugFests per year, to accommodate for ever increasing interest of the diverse O-RAN community to efficiently test and integrate their O-RAN solutions.
O-RAN Global PlugFest Spring 2022 took place at 3 continents with 50 participating companies or institutions, some of which participated at more than one venue.
In North America, the O-RAN ‘PoCFest’ hosted by AT&T and DISH spanned across 4 labs in cooperation with several universities:
- TIP Community Lab at Meta, Menlo Park CA
- POWDER Lab and NSF PAWR SITE with the University of Utah
- COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless
- InterOperability Lab at the University of New Hampshire
Activities focused on demonstrations of use cases within the O-RAN Use Cases Detailed Specification version 6.0 & 7.0, as well as use cases that are currently in the process of being specified such as Energy Saving / Energy Efficiency. More than 20 unique O-RAN components were tested for conformance to O-RAN specifications.
The Proof-of-Concept approach also supported the evolution of testbeds across companies and research institutions, which is expected to accelerate the availability of next generation research platforms, consistent with the mission of the recently established nGRG within O-RAN.
In addition to the hosts and labs, participants included Analog Devices, Anritsu, Calnex Solutions, Cisco, Fujitsu, HCL, highstreet technologies, IP Infusion, ITRI, Juniper Networks, Keysight Technologies, META, NSF ARA: Living Wireless Lab, NSF PAWR: AERPAW, NSF PAWR: Colosseum, Rohde & Schwarz, VIAVI Solutions, VMware and Wind River .
In Europe, the O-RAN PlugFest Spring 2022 hosted by Telefonica took place at the European OTIC in Madrid.
Activities focused on testing of open Xhaul transport solutions, including data plane functional and performance testing, as well as synchronization. Testing scenarios were mimicking realistic deployments with diversity of technologies, protocols, and encapsulations, to obtain meaningful insights on the solutions under test. There were three setups with different transport equipment, two instrumentation vendors, and one transceiver manufacturer.
In addition to the host, participants included ADVA Optical Networking, Juniper Networks, Keysight Technologies, Precision Optical Transceivers, Ribbon and VIAVI Solutions .
In Asia, O-RAN PlugFest Spring 2022 hosted by Auray took place at the Auray OTIC and Security Lab.
Divided into 18 test cases, activities focused on verification and validation of applicability of tests in a lab environment, specifically for Open Fronthaul tests, end-to-end tests, and Denial of Service (DoS) and blind exploitation types of security tests.
Performed actions covered a dry run of the O-RAN Certification and Badging, verifying the related processes and procedures.
The PlugFest also included Open RAN Testing and Optimization for Industry IoT – smart scoring methodology for end-to-end service experience based on 3GPP 5G E2E KPIs.
In addition to the host, participants included Alpha Networks, Askey Computer, Calnex Solutions, Foxconn, Institute for Information Industry, Inventec, IP Infusion, ITRI, JPC connectivity, Keysight Technologies, Lions Technology, LITEON, MICAS, NKG, Pegatron, QCT, REIGN Technology, Rohde & Schwarz, Sageran, VIAVI Solutions and WNC .
The O-RAN ALLIANCE is preparing a web announcement and a Virtual Showcase to allow interested public to explore the O-RAN Global PlugFest Spring 2022 in detail – soon to be available at our website .
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 340 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220630005362/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom